Infinity Pharmaceuticals | INFI - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
AbbVie USD 3.89B 325M 2025-12
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.33M 50K 2025-09
CSL USD 1.23B 498M 2025-12
Eisai JPY 111.72B 7.86B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 333.1M 157M 2025-09
Incyte USD 390.41M 61.33M 2025-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
J&J USD 6.75B 831M 2025-12
Novartis USD 3.31B 134M 2025-09
Pfizer USD 4.08B 894M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
TG Therapeutics USD 50.73M 12.64M 2025-12